The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

Objective: The study goal was to determine the efficacy and safety of an optimal dose of Evekeo, racemic amphetamine sulfate, 1:1 d-amphetamine and l-amphetamine (R-AMPH), compared to placebo in treating children with attention-deficit/hyperactivity disorder (ADHD) in a laboratory classroom setting....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Child Adolesc Psychopharmacol
Päätekijät: Childress, Ann C., Brams, Matthew, Cutler, Andrew J., Kollins, Scott H., Northcutt, Jo, Padilla, Americo, Turnbow, John M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mary Ann Liebert, Inc. 2015
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491157/
https://ncbi.nlm.nih.gov/pubmed/25692608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2014.0176
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia